Bimodal Fluorescence and Magnetic Resonance Imaging Using Water-Soluble Hexagonal NaYF 4 :Ce,Tb,Gd Nanocrystals

A Room-Temperature Strategy to Synthesize Ce/Tb-Codoped NaYF4 Nanoparticles with a Photoluminescence Quantum Yield Exceeding 50

NaYF4:Ce3+,Tb3+ down-conversion nanoparticles with a photoluminescence quantum yield (PLQY) of 54.8% are synthesized by using a ligand-assisted coprecipitation method in this study. The reaction is completed within 1 min at room temperature, and short-chain hexanoic acid and hexylamine serve as the binary ligands, which enable us to synthesize highly luminescent NaYF4:Ce3+,Tb3+ nanoparticles at room temperature. X-ray diffraction (XRD) and transmission electron microscopy (TEM) are used to characterize the as-prepared nanocrystals. The results reveal that the NaYF4:Ce3+,Tb3+ nanocrystals exhibit excellent dispersion and have a particle size of 2.7 nm. Our NaYF4:Ce3+,Tb3+ nanocrystals possess the advantages of room-temperature preparation, high PLQY, and ultrasmall particle size. These results reveal that the NaYF4:Ce3+,Tb3+ nanocrystals might have a high potential in the applications of lighting, display devices, and bioimaging.

Influence of Gd3+ doping concentration on the properties of Na(Y,Gd)F4:Yb3+, Tm3+ upconverting nanoparticles and their long-term aging behavior

We present a systematic study on the properties of Na(Y,Gd)F₄-based upconverting nanoparticles (UCNP) doped with 18% Yb³⁺, 2% Tm³⁺, and the influence of Gd³⁺ (10-50 mol% Gd³⁺). UCNP were synthesized via the solvothermal method and had a range of diameters within 13 and 50 nm. Structural and photophysical changes were monitored for the UCNP samples after a 24-month incubation period in dry phase and further redispersion. Structural characterization was performed by means of X-ray diffraction (XRD), transmission electron microscopy (TEM) as well as dynamic light scattering (DLS), and the upconversion luminescence (UCL) studies were executed at various temperatures (from 4 to 295 K) using time-resolved and steady-state spectroscopy. An increase in the hexagonal lattice phase with the increase of Gd³⁺ content was found, although the cubic phase was prevalent in most samples. The Tm³⁺-luminescence intensity as well as the Tm³⁺-luminescence decay times peaked at the Gd³⁺ concentration of 30 mol%. Although the general upconverting luminescence properties of the nanoparticles were preserved, the 24-month incubation period lead to irreversible agglomeration of the UCNP and changes in luminescence band ratios and lifetimes.

Gadolinium(III)-Chelated Silica Nanospheres Integrating Chemotherapy and Photothermal Therapy for Cancer Treatment and Magnetic Resonance Imaging

The combination of therapy and diagnosis has been emerging as a promising strategy for cancer treatment. To realize chemotherapy, photothermal therapy, and magnetic resonance imaging (MRI) in one system, we have synthesized a new magnetic nanoparticle (Gd@SiO2-DOX/ICG-PDC) integrating doxorubicin (DOX), indocyanine green (ICG), and gadolinium(III)-chelated silica nanospheres (Gd@SiO2) with a poly(diallyldimethylammonium chloride) (PDC) coating. PDC coating serves as a polymer layer to protect from quick release of drugs from the nanocarriers and increase cellular uptake. The DOX release from Gd@SiO2-DOX/ICG-PDC depends on pH and temperature. The process will be accelerated in the acidic condition than in a neutral pH 7.4. Meanwhile, upon laser irradiation, the photothermal effects promote DOX release and improve the therapeutic efficacy compared to either DOX-loaded Gd@SiO2 or ICG-loaded Gd@SiO2. Moreover, MRI results show that the Gd@SiO2-PDC nanoparticles are safe T1-type MRI contrast agents for imaging. The Gd@SiO2-PDC nanoparticles loaded with DOX and ICG can thus act as a promising theranostic platform for multimodal cancer treatment.